Skip to content
Viagra LabsViagra Labs
Tadalista 20mg
Tadalista 20mg

Tadalista (tadalafil)

Tadalista is a tadalafil tablet family attributed to Fortune Healthcare in the source record.

Active ingredient
tadalafil
Formulation
Oral tablet
Company in catalogue
Fortune Healthcare Product Pvt Ltd

Tadalista is a tadalafil tablet family attributed to Fortune Healthcare in the source record. It is distinct from Tadalis SX, despite the similar spelling, and from Tadalista Professional and Super Active formulations.

What distinguishes this product

The ordinary-tablet entry includes claimed strengths from 2.5 to 60 mg. Keep that catalogue range separate from a prescribed regimen and from the strengths documented for a particular country. Neither a higher number nor the product suffix establishes greater clinical benefit.

Product record

Record type
Indian branded generic
Treatment area in this directory
Erectile dysfunction (ED)
Active ingredient
tadalafil
Formulation in the cited record
Oral tablet
Source-listed strengths
2.5 mg, 5 mg, 10 mg, 20 mg, 40 mg, 60 mg
Company in the cited record
Fortune Healthcare Product Pvt Ltd (Company attributed by the source catalogue)
Manufacturing information
A specific manufacturing site is not established by the cited catalogue record. Consult the country-specific label and pack.
Market evidence
Global reference; exact market authorization not established by this catalogue import
Storage reported by source
Store below 30°C Check the supplied leaflet for the exact presentation.
Catalogue reviewed

Catalogue attributes describe the named product as reported by the source. Listed strengths are identification details, not dosing instructions. Ingredient evidence and company identity are useful signals; local product authorization is a separate question.

Ingredient references

These references cover the active ingredients. They do not verify every named brand, pack or formulation listed on this page.

How the ingredients fit treatment

Tadalafil is a PDE5 inhibitor with a longer duration of action than sildenafil. Its documented ED regimens include daily and as-needed treatment, using different prescribed strengths. A catalogue strength alone does not identify which regimen is appropriate.

Ingredient guidance and safe use

Read the ingredient guidance alongside the leaflet for the actual product. A different brand, strength or dosage form may need different instructions.

Do not combine a PDE5 inhibitor with nitrates, recreational nitrites (“poppers”) or riociguat. Seek urgent medical help for chest pain, an erection lasting more than four hours, or sudden loss of vision or hearing. Tell the treating team which medicine you took and when.

Commonly reported effects of oral PDE5 medicines include headache, flushing, indigestion and nasal congestion; the pattern varies by ingredient and product. The cited ingredient information covers adverse effects and restrictions in more detail.

Interactions and urgent symptoms · Understanding formulations · Finding a local medicine record

Related product records